1565 Results

People

  1. Hudis
    Hudis
  2. Norton
    Norton
  3. Robson
    Robson
  4. Rosen
    Rosen
  5. Patil
    Patil
  6. Modi
    Modi
  7. Traina
    Traina
  8. Seidman
    Seidman
  9. Solit
    Solit
  10. Dang
    Dang

Groups

  1. Breast Medicine Service (1565)
  2. Department of Medicine (1565)
  3. Solid Tumor Oncology Division (1565)
  4. Survivorship Research (911)
  5. GSK Faculty (588)
  6. Population Sciences Research Program (524)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (430)
  8. Epidemiology and Biostatistics (383)
  9. Human Oncology and Pathogenesis Program (332)
  10. Biostatistics Service (286)
  1. "Meeting abstract"
  2. "Breast Medicine Service"
Formats
  1. Meeting Abstract (1565)
Groups
  1. Breast Medicine Service (1565)
  2. Department of Medicine (1565)
  3. Solid Tumor Oncology Division (1565)
  4. Survivorship Research (911)
  5. GSK Faculty (588)
  6. Population Sciences Research Program (524)

More Groups

People
  1. Clifford Hudis (393)
  2. Larry Norton (288)
  3. Mark Robson (248)
  4. Neal Rosen (185)
  5. Sujata Patil (151)
  6. Shanu Modi (142)

More People

Years
  1. 2023 (68)
  2. 2022 (85)
  3. 2021 (87)
  4. 2020 (142)
  5. 2019 (115)
  6. 2018 (105)

More Years

Publications
  1. Journal of Clinical Oncology (509)
  2. Cancer Research (427)
  3. Annals of Oncology (82)
  4. Breast Cancer Research and Treatment (55)
  5. Blood (49)
  6. Proceedings of the American Association for Cancer Research Annual Meeting (46)

More Publications

Publishers
  1. American Society of Clinical Oncology (509)
  2. American Association for Cancer Research (507)
  3. Elsevier Inc. (105)
  4. Oxford University Press (98)
  5. Springer (88)
  6. American Society of Hematology (49)

More Publishers

Results (1565)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Network modeling of apoptosis-related genes reveal a high-risk cluster in multiple myeloma
    Meeting Abstract

    Simhal, A. K.; Maclachlan, K. H.; Usmani, S. Z.; Norton, L.; Deasy, J. O.; Oh, J. H.; Tannenbaum, A.
    Blood (2023)

    Fulltext@MSK | Save
  • A whole foods plant-based weight loss intervention improves quality of life, metabolic, microbiome and immune profile in MGUS/SMM as well as progression trajectory in a subset - the Nutrivention trial
    Meeting Abstract

    Shah, U. A.; Castro, F.; Derkach, A.; Fei, T.; Hosszu, K. K.; McAvoy, D.; DeWolf, S.; Cross, J.; Gradissimo, A.; Nwankwo, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Public tumor-wide neoantigens derived from clonal aberrant splicing events drive tumor-specific T-cell responses
    Meeting Abstract

    Kwok, D.; Stevers, N.; Nejo, T.; Jung, J.; Chen, L.; Lakshmanachetty, S.; Etxeberria, I.; Gallus, M.; Yamamichi, A.; Ramos, E.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • DNA liquid biopsies for cancer-associated venous thromboembolism prediction
    Meeting Abstract

    Jee, J.; Brannon, A. R.; Fong, C.; Lee, A.; Gray, L.; Pichotta, K.; Luthra, A.; Diosdado, M.; Haque, M.; Guo, J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Vaginal and vulvar symptoms in patients with ESR1-mutated, ER+/ HER2- metastatic breast cancer by baseline characteristics
    Meeting Abstract

    Goldfarb, S. B.; Sammons, S.; Meisel, J. L.; Pluard, T. J.; Jenkins, S. N.; Komm, B.; Carroll, D.; Portman, D. J.
    Menopause (2023)

    Fulltext@MSK | Save
  • Final overall survival (OS) analysis from the phase 3 TROPiCS-02 study of sacituzumab govitecan (SG) in patients (pts) with hormone receptor-positive/HER2-negative (HR+/HER2-) metastatic breast cancer (mBC)
    Meeting Abstract

    Tesch, H.; Tolaney, S.; Bardia, A.; Marmé, F.; Cortes, J.; Schmid, P.; Loirat, D.; Tréedan, O.; Ciruelos, E.; Dalenc, F.; more...
    Oncology Research and Treatment (2023)

    Fulltext@MSK | Save
  • Risk of radiation-associated secondary malignancies among patients with breast cancer harboring TP53 germline variants
    Meeting Abstract

    Cederquist, G.; Boe, L.; Walsh, M. F.; Stadler, Z.; Xu, A. J.; Mueller, B. A.; Roth O'Brien, D. A.; Bernstein, M. B.; Cuaron, J.; Bakhoum, S. F.; more...
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save
  • T-DXd vs TPC in patients with HER2-low unresectable and/or metastatic BC in Asian subgroup: Results of DESTINY-Breast04
    Meeting Abstract

    Tsurutani, J.; Modi, S.; Sohn, J. H.; Tokunaga, E.; Niikura, N.; Park, Y. H.; Lee, K. S.; Chae, Y. S.; Wang, X.; Li, W.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Novel therapeutic opportunities in metaplastic breast cancer
    Meeting Abstract

    Pareja, F.; Gazzo, A.; Dopeso, H.; Brown, D.; Selenica, P.; Zhu, Y.; Blanco Heredia, J.; Gusain, L.; Pei, X.; Marra, A.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Datopotamab deruxtecan (Dato-DXd) vs chemotherapy in previously-treated inoperable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer (BC): Primary results from the randomised phase III TROPION-Breast01 trial
    Meeting Abstract

    Bardia, A.; Jhaveri, K.; Im, S. A.; Pernas Simon, S.; De Laurentiis, M.; Wang, S.; Martinez, N.; Santos Borges, G.; Cescon, D. W.; Hattori, M.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save